Session information

[CINP2024] Spotlight Session

CINP2024 » Spotlight Session

Spotlight Session 3
Recent Topics in Research and Development of Drugs for Treating Neuropsychiatric Disorders

Fri. May 24, 2024 3:00 PM - 4:00 PM Room 1 (Hall C)

Chair: Christoph U. Correll (Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA), Tetsuro Kikuchi (Otsuka Pharmaceutical)

+Add all to schedule

[SS3-1] Exploring Muscarinic Receptors in Schizophrenia: A Renewed Approach to Developing Innovative Antipsychotics That Go Beyond Dopamine Receptor Antagonism

*Ken Kramer¹ (1. Karuna Therapeutics )

[SS3-2] Brexpiprazole: A Review of the New Treatment Approved for Agitation Associated with Dementia due to Alzheimer‘s Disease

*Malaak Brubaker¹ (1. Otsuka Pharmaceutical Development & Commercialization, Inc.)

[SS3-3] Exploring Innovative Avenues in the Treatment of Alzheimer's Disease

*Teiji Kimura¹ (1. Eisai Co., Ltd.)

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Please log in with your participant account.
» Participant Log In

▲